BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lysaght T. Accelerating regenerative medicine: the Japanese experiment in ethics and regulation. Regenerative Medicine 2017;12:657-68. [DOI: 10.2217/rme-2017-0038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Rosemann A. Alter-Standardizing Clinical Trials: The Gold Standard in the Crossfire. Science as Culture 2018;28:125-48. [DOI: 10.1080/09505431.2019.1606190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
2 Rosemann A, Barfoot J, Blackburn C. Special focus issue on regenerative medicine in society: interdisciplinary perspectives (part I) - Foreword. Regen Med 2017;12:577-80. [PMID: 29017381 DOI: 10.2217/rme-2017-0117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Bin Abdul Aziz MF, Morrison M, Kaye J. Creative regulatory practices to develop stem-cell technology: the way forward for Malaysia. Regen Med 2021. [PMID: 34905952 DOI: 10.2217/rme-2021-0068] [Reference Citation Analysis]
4 Rosemann A, Vasen F, Bortz G. Global Diversification in Medicine Regulation: Insights from Regenerative Stem Cell Medicine. Science as Culture 2018;28:223-49. [DOI: 10.1080/09505431.2018.1556253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Munsie M, Lysaght T, Hendl T, Tan HL, Kerridge I, Stewart C. Open for business: a comparative study of websites selling autologous stem cells in Australia and Japan. Regen Med. 2017;12:777-790. [PMID: 29125016 DOI: 10.2217/rme-2017-0070] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
6 Kim DS, Lee G, Cho H, Bae S. Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement. Front Bioeng Biotechnol 2021;9:737504. [PMID: 34527662 DOI: 10.3389/fbioe.2021.737504] [Reference Citation Analysis]
7 Takashima K, Morrison M, Minari J. Reflection on the enactment and impact of safety laws for regenerative medicine in Japan. Stem Cell Reports 2021;16:1425-34. [PMID: 34019814 DOI: 10.1016/j.stemcr.2021.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Umemura M, Morrison M. Comparative lessons in regenerative medicine readiness: learning from the UK and Japanese experience. Regen Med 2021;16:269-82. [PMID: 33781099 DOI: 10.2217/rme-2020-0136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]